Primary, secondary, and catastrophic antiphospholipid syndrome: What's in a name?

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue 3, 2008, Pages 219-226

  Harris, E Nigel ^a   Pierangeli, Silvia S ^b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Anticardiolipin antibody test; Antiphospholipid antibodies, anti 2 glycoprotein I; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; GLYCOPROTEIN IIB; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTICARDIOLIPIN TEST; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUSTRALIA; CRITERION RELATED VALIDITY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVEDO RETICULARIS; LUNG EMBOLISM; MIGRAINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPINAL CORD DISEASE; SPONTANEOUS ABORTION; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VEIN THROMBOSIS;

ABORTION, HABITUAL; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; TERMINOLOGY AS TOPIC; THROMBOPHILIA;

EID: 50249114024     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0028-1082265     Document Type: Article

References (54)

1. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952;31:621-622
2. Lechner K. Acquired inhibitors in auto and isoimmune diseases. Haemostasis 1974;3:65-93
3. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. In Spaet TN, ed. Progress in Hemostasis and Thrombosis, 1st ed. New York, NY: Grune and Stratton; 1982:75-95
4. Shapiro SS, Thiagarajan P. Lupus anticoagulant. Prog Hemost Thromb 1982;6:263-285
5. Bowie EJW, Thompson JH, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;62:416-430
6. Soulier JP, Boffa MC. Avortements a` re´pe´ tition, thromboses, et anticoagulant circulant anti-thromoboplastine. Nouv Presse Med 1980;9:859-864
7. Carreras LO, Vermylen JG. "Lupus" anticoagulant and thrombosis - possible role of inhibition of prostacyclin formation. Thromb Haemost 1982;48:38-40
8. Boey ML, Colaco CB, Gharavi AE, et al. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating anticoagulant. BMJ 1983;287:1021-1023
9. Nilsson IM, Asstedt B, Hedner U, et al. Intrauterine death and circulating anticoagulant "antithromboplastin." Acta Med Scand 1975;197:153-159
10. Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980;92:156-159
11. Hughes GRV. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol 1984;9:535-544
12. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-1214
13. Harris EN, Gharavi AE, Loizou S, et al. Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985;16:1-6
14. Harris EN, Gharavi AE, Hughes GRV. Anti-phospholipid antibodies. Clin Rheum Dis 1985;11:591-606
15. Lubbe WF, Palmer SJ, Butler WS, Laggins GC. Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983;i:1361-1363
16. Asherson RA, Chan JKH, Harris EN, et al. Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawal. Ann Rheum Dis 1985;44:823-825
17. Harris EN, Chan JKH, Asherson RA, et al. Thrombosis, recurrent fetal loss and thrombocytopemia: predictive value of the anticardiolipin test. Arch Intern Med 1986;146:2153-2156
18. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-222
19. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489
20. Harris EN. Syndrome of the Black Swan. Br J Rheumatol 1987;26:324-326
21. Asherson RA. A primary anti-phospholipid syndrome? J Rheumatol 1988;15:1742-1745
22. Alarcon Segovia D, Sanchez - Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482-487
23. Asherson RA. The catastrophic antiphospholipid antibody syndrome. J Rheumatol 1992;19:508-512
24. Greisman SG, Thaya Paran RS, Godwin TA, Lockshin MD. Occlusive vasculopathy in systemic lupus erythematosus - association with anticardiolipin antibody. Arch Intern Med 1991;151:389-392
25. Harris EN, Bos K. An acute disseminated coagulopathy - vasculopathy associated with the antiphospholipid syndrome. Arch Intern Med 1991;151:231-232
26. McNeil HP, Simpson J, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes lipid binding inhibitor of coagulation: beta-2-glycoprotein I (apolipoprotein II). Proc Natl Acad Sci U S A 1990;87:4120-4124
27. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;355:1544-1547
28. Matsuura E, Igarashi Y, Yasuda T, et al. Anticardiolipin antibodies recognize β2 glycoprotein 1 structure altered bv interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-462
29. Galli M, Lucian D, Bertolini G, Barbui J. Anti-beta2-glycoprotein 1, anti-prothrombin antibodies and the risk of thrombosis on the antiphospholipid syndrome. Blood 2003;102:2717-2723
30. Reber G, deMoerloose P. Anti-beta2-glycoprotein 1 antibodies - when and how they should be measured? Thromb Res 2004;114:527-531
31. Faden D, Tincani A, Tanzi P, et al. Anti-beta2 glycoprotein 1 antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein 1 antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997;73:37-42
32. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006;4:295-306
33. Lackner KJ, Peetz D, Von Landenberg P. Revision of the Sapporo criteria for the antiphospholipid syndrome - coming to grips with evidence and Thomas Bayes? Thromb Haemost 2006;95:917-919
34. Nash MJ, Camilleri RS, Kunka S. The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost 2004;2:1077-1081
35. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-1311
36. Escalante A, Brey RL, Mitchell BD, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995;98:559-565
37. Levine SR, Salowich-Palm L, Sawaya KL, et al. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study. Stroke 1997;28:1660-1665
38. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21:275-286
39. Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000;43:440-443
40. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3-9
41. Asherson RA, Cervera R, deGroot PG, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003;12:530-534
42. Tan EM, Cohen AS, Fries JF, et al. Revised criteria for the classification of system lupus erythematosus. Arthritis Rheum 1982;25:1271-1277
43. The APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004;291:576-584
44. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003;101:1333-1344
45. Harris EN. The Second International Anti-cardiolipin Standardization workshop/the Kingston Anti-phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990;94:476-484
46. Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002;11:269-276
47. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations - a cooperative project of the European Antophospholipid Forum. Thromb Haemost 2001;86:575-583
48. Wong RCW, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004;36:63-68
49. Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999;31:142-147
50. Pierangeli SS, Harris EN. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is? Semin Thromb Hemost 2008;34: (in press)
51. Lopez-Soto A, Cervera R, Font J, et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid phosphatidyl inositol and phosphatidyl serine in systemic lupus erythematosus: prosective analysis in a series of 92 patients. Clin Exp Rheumatol 1997;15:143-149
52. Branch DW, Silver R, Pierangeli S, et al. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol 1997;89:549-555
53. Merkel PA, Chang Y, Pierangeli SS, Harris EN, Polisson RP. Comparison between the standard anticardiolipin antibody assay and a new phospholipid assay in patients with a variety of connective tissue diseases. J Rheumatol 1999;26:591-596
54. Atsumi T, Ieko M, Bertolccini M, et al. Association of autoantibodies against the phosphatidyl serine-prothrobim complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000;43:1982-1993